Bioenergetic defects and abnormalities in glutamate neurotransmission
have both been proposed to play important roles in neurological diseas
es of varying chronology, etiology and pathology. Recent experimental
evidence suggests an intimate relationship between these two systems.
Metabolic inhibition predisposes neurons to glutamate-mediated ''excit
otoxic'' damage. The exact mechanism of this increased susceptibility
is yet to be defined, but may involve, singly or in combination, decre
ased voltage-dependent Mg2+ blockade of the N-methyl-D-aspartate (NMDA
) subtype of glutamate receptor, abnormalities in cellular Ca2+ homeos
tasis, or elevated production of reactive oxygen species. It is believ
ed that enhancement of excitotoxicity by impaired metabolism may be a
ubiquitous mechanism of neuronal death in neurological disease. Furthe
r elucidation of the exact mechanism of this enhancement may lead to t
he discovery of new targets for therapeutic intervention. Copyright (C
) 1996 Elsevier Science Ltd